Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- Status
- COMPLETED
- Phase
- PHASE3
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- Status
- WITHDRAWN
- Phase
- PHASE2
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
- Status
- COMPLETED
- Phase
- N/A
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives
- Status
- COMPLETED
- Phase
- N/A
Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass
- Status
- COMPLETED
- Phase
- PHASE1
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide
- Status
- COMPLETED
- Phase
- PHASE1
A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
- Status
- COMPLETED
- Phase
- N/A
Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India
- Status
- COMPLETED
- Phase
- N/A
Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.
- Status
- COMPLETED
- Phase
- PHASE3
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
- Status
- COMPLETED
- Phase
- N/A
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1